156 related articles for article (PubMed ID: 26484904)
1. Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes.
Bergeron D; Beauregard JM; Guimond J; Fortin MP; Houde M; Poulin S; Verret L; Bouchard RW; Laforce R
J Alzheimers Dis; 2016; 49(3):695-705. PubMed ID: 26484904
[TBL] [Abstract][Full Text] [Related]
2. Management impact of FDG-PET in dementia: results from a tertiary center memory clinic.
Elias A; Woodward M; Rowe CC
J Alzheimers Dis; 2014; 42(3):885-92. PubMed ID: 24961944
[TBL] [Abstract][Full Text] [Related]
3. Impact of molecular imaging on the diagnostic process in a memory clinic.
Ossenkoppele R; Prins ND; Pijnenburg YA; Lemstra AW; van der Flier WM; Adriaanse SF; Windhorst AD; Handels RL; Wolfs CA; Aalten P; Verhey FR; Verbeek MM; van Buchem MA; Hoekstra OS; Lammertsma AA; Scheltens P; van Berckel BN
Alzheimers Dement; 2013 Jul; 9(4):414-21. PubMed ID: 23164552
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias.
Taswell C; Villemagne VL; Yates P; Shimada H; Leyton CE; Ballard KJ; Piguet O; Burrell JR; Hodges JR; Rowe CC
J Nucl Med; 2015 Oct; 56(10):1547-53. PubMed ID: 26251415
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.
Bensaïdane MR; Beauregard JM; Poulin S; Buteau FA; Guimond J; Bergeron D; Verret L; Fortin MP; Houde M; Bouchard RW; Soucy JP; Laforce R
J Alzheimers Dis; 2016 Apr; 52(4):1251-62. PubMed ID: 27104896
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.
Dukart J; Mueller K; Horstmann A; Vogt B; Frisch S; Barthel H; Becker G; Möller HE; Villringer A; Sabri O; Schroeter ML
Neuroimage; 2010 Jan; 49(2):1490-5. PubMed ID: 19770055
[TBL] [Abstract][Full Text] [Related]
7. Brain FDG PET and the diagnosis of dementia.
Shivamurthy VK; Tahari AK; Marcus C; Subramaniam RM
AJR Am J Roentgenol; 2015 Jan; 204(1):W76-85. PubMed ID: 25539279
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
Foster NL; Heidebrink JL; Clark CM; Jagust WJ; Arnold SE; Barbas NR; DeCarli CS; Turner RS; Koeppe RA; Higdon R; Minoshima S
Brain; 2007 Oct; 130(Pt 10):2616-35. PubMed ID: 17704526
[TBL] [Abstract][Full Text] [Related]
9. Autopsy as gold standard in FDG-PET studies in dementia.
Durand-Martel P; Tremblay D; Brodeur C; Paquet N
Can J Neurol Sci; 2010 May; 37(3):336-42. PubMed ID: 20481267
[TBL] [Abstract][Full Text] [Related]
10. Fluorodeoxyglucose-positron emission tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study.
Panegyres PK; Rogers JM; McCarthy M; Campbell A; Wu JS
BMC Neurol; 2009 Aug; 9():41. PubMed ID: 19674446
[TBL] [Abstract][Full Text] [Related]
11. [18 FDG PET imaging of the brain in the analysis of a dementia syndrome].
Golüke-Willemse GA; Csepán-Magyar R; Rijnders AJ
Tijdschr Gerontol Geriatr; 2012 Oct; 43(5):265-9. PubMed ID: 23167069
[TBL] [Abstract][Full Text] [Related]
12. Guidance for reading FDG PET scans in dementia patients.
Herholz K
Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):332-43. PubMed ID: 25391316
[TBL] [Abstract][Full Text] [Related]
13. Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [
Hellwig S; Frings L; Bormann T; Vach W; Buchert R; Meyer PT
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):312-323. PubMed ID: 30094462
[TBL] [Abstract][Full Text] [Related]
14. The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: A retrospective memory clinic study.
Laforce R; Buteau JP; Paquet N; Verret L; Houde M; Bouchard RW
Am J Alzheimers Dis Other Demen; 2010 Jun; 25(4):324-32. PubMed ID: 20539026
[TBL] [Abstract][Full Text] [Related]
15. Top-Down Systematic Approach to Interpretation of FDG-PET for Dementia.
Sawyer DM; Kuo PH
Clin Nucl Med; 2018 Jun; 43(6):e212-e214. PubMed ID: 29659399
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic impact of [
Zwan MD; Bouwman FH; Konijnenberg E; van der Flier WM; Lammertsma AA; Verhey FR; Aalten P; van Berckel BN; Scheltens P
Alzheimers Res Ther; 2017 Jan; 9(1):2. PubMed ID: 28093088
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET Imaging of Dementia and Neurodegenerative Disease.
Dave A; Hansen N; Downey R; Johnson C
Semin Ultrasound CT MR; 2020 Dec; 41(6):562-571. PubMed ID: 33308495
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
Hellwig S; Frings L; Amtage F; Buchert R; Spehl TS; Rijntjes M; Tüscher O; Weiller C; Weber WA; Vach W; Meyer PT
J Nucl Med; 2015 Oct; 56(10):1541-6. PubMed ID: 26229141
[TBL] [Abstract][Full Text] [Related]
19. Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET.
Brendel M; Schnabel J; Schönecker S; Wagner L; Brendel E; Meyer-Wilmes J; Unterrainer M; Schildan A; Patt M; Prix C; Ackl N; Catak C; Pogarell O; Levin J; Danek A; Buerger K; Bartenstein P; Barthel H; Sabri O; Rominger A
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2239-2248. PubMed ID: 28932894
[TBL] [Abstract][Full Text] [Related]
20. The value of FDG-PET/CT by using 3-dimensional stereotactic surface projection software analysis in the differential diagnosis of dementia.
Arslan E; Ekmekçioğlu Ö; Görtan FA; Engin Akcan ZF; Erkan ME; Emül HM; Halaç M; Çermik TF; Sönmezoğlu K
Turk J Med Sci; 2015; 45(5):1149-58. PubMed ID: 26738361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
